SCHEMBL1703970

SCHEMBL1703970

C[C@H]1CN(Cc2ccc(Br)cc2)CCN1C(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.53
PDK2 Q15119 1/20 0.53
PDK3 Q15120 1/20 0.53
PDK4 Q16654 1/20 0.53
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
MGLL Q99685 1/20 0.48
HTR2C P28335 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
CACNA1G O43497 1/20 0.46
CACNA1H O95180 1/20 0.46
CACNA1I Q9P0X4 1/20 0.46
SIGMAR1 Q99720 1/20 0.45
CCR1 P32246 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14646619 0.93 PDK1 (0.59) PDK1PDK2PDK3PDK4MGLL
SCHEMBL1633894 0.89 PDK1 (0.52) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL1705195 0.89 PDK1 (0.53) PDK1PDK2PDK3PDK4MGLL
SCHEMBL1704568 0.89 PDK1 (0.53) PDK1PDK2PDK3PDK4MGLL
SCHEMBL4175784 0.86 PDK1 (0.51) PDK1PDK2PDK3PDK4MGLL
SCHEMBL1703905 0.86 PDK1 (0.51) PDK1PDK2PDK3PDK4HTT
SCHEMBL7809947 0.85 MGLL (0.51) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL13895357 0.83 PDK1 (0.59) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL13895353 0.83 PDK1 (0.59) PDK1PDK2PDK3PDK4HTR2C
SCHEMBL4175788 0.83 PDK1 (0.48) PDK1PDK2PDK3PDK4MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2441763-A1 Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders Glaxo Group Limited (GB) 2012-04-18 EP disclosed